SMI Expanded
1.647,52
PKT
+7,25
PKT
+0,44
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.04.05 | Richemont Overweight | JP Morgan | |
| 26.04.05 | Nestlé In-Line | Goldman Sachs | |
| 27.04.05 | Roche Buy | Helvea | |
| 02.05.05 | Richemont Kaufen | Hamburger Sparkasse | |
| 26.04.05 | Nestlé Sector Outperform | Vontobel | |
| 27.04.05 | Roche Kaufen | Hamburger Sparkasse | |
| 27.04.05 | Richemont Accumulate | Helvea | |
| 26.04.05 | Nestlé Overweight | JP Morgan | |
| 26.04.05 | Richemont Buy | Sarasin Research | |
| 26.04.05 | Nestlé Akkumulieren | Independent Research | |
| 26.04.05 | Richemont Outperform | Goldman Sachs | |
| 26.04.05 | Geberit Buy | Sarasin Research | |
| 26.04.05 | Geberit Market Outperform | Vontobel | |
| 26.04.05 | Holcim Overweight | JP Morgan | |
| 26.04.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 26.04.05 | Holcim Halten | Helaba Trust | |
| 26.04.05 | Swiss Life Buy | SRC Research | |
| 26.04.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 26.04.05 | Straumann Outperform | Goldman Sachs | |
| 22.04.05 | Novartis Hold | SEB | |
| 25.04.05 | Straumann Sector Perform | Vontobel | |
| 22.04.05 | Novartis Overweight | Lehman Brothers | |
| 22.04.05 | Novartis Outperform | Goldman Sachs | |
| 27.04.05 | Novartis Kaufen | NATIONAL-BANK | |
| 21.04.05 | Roche Outperform | Goldman Sachs | |
| 21.04.05 | Geberit Buy | Sarasin Research | |
| 21.04.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 21.04.05 | Novartis Neutral | Sarasin Research | |
| 21.04.05 | Roche Sector Outperform | Vontobel | |
| 25.04.05 | Lindt Neutral | Sarasin Research | |
| 21.04.05 | Novartis Buy | Merrill Lynch | |
| 21.04.05 | Nestlé Neutral | Sarasin Research | |
| 21.04.05 | Novartis Akkumulieren | Independent Research | |
| 22.04.05 | Novartis Kaufen | Helaba Trust | |
| 20.04.05 | Roche Outperform | Goldman Sachs | |
| 20.04.05 | Nestlé Overweight | JP Morgan | |
| 20.04.05 | Roche Equal weight | Lehman Brothers | |
| 20.04.05 | Nestlé In-Line | Goldman Sachs | |
| 20.04.05 | Roche Overweight | JP Morgan | |
| 20.04.05 | Nestlé Kaufen | Helaba Trust |